{"id":"glybenclamide","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["Second oral agent to be added"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-27T23:33:03.648Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06907472","phase":"NA","title":"Diabetes Management for Primary Healthcare Centers.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Abuja","startDate":"2025-09-15","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":106},{"nctId":"NCT05426681","phase":"PHASE1","title":"Spinal Cord Injury Neuroprotection With Glyburide","status":"RECRUITING","sponsor":"Francis Farhadi","startDate":"2022-07-07","conditions":"Acute Spinal Cord Injury","enrollment":12},{"nctId":"NCT05220917","phase":"","title":"Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-08-01","conditions":"Cardiovascular Events, Type2 Diabetes, Renal Disease","enrollment":781430},{"nctId":"NCT00610038","phase":"PHASE2","title":"Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2006-07","conditions":"Diabetes Mellitus","enrollment":19},{"nctId":"NCT05687500","phase":"PHASE2","title":"Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-20","conditions":"Transient; Hypoglycemia, Neonatal, Preterm, Glibenclamide Adverse Reaction","enrollment":35},{"nctId":"NCT07221799","phase":"PHASE1","title":"OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-09-01","conditions":"Multiple Sclerosis, Neuropathic Pain","enrollment":10},{"nctId":"NCT02375828","phase":"PHASE3","title":"Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-03-20","conditions":"Neonatal Diabetes Secondary to Mutation in the Potassium Channel","enrollment":10},{"nctId":"NCT01731431","phase":"PHASE3","title":"Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-05-18","conditions":"Diabetes, Gestational","enrollment":914},{"nctId":"NCT03492580","phase":"","title":"A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-02-22","conditions":"Diabetes Mellitus, Type 2, Cardiovascular Diseases","enrollment":714582},{"nctId":"NCT01242215","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2010-09-17","conditions":"Type 2 Diabetes Mellitus","enrollment":243},{"nctId":"NCT05910554","phase":"PHASE2","title":"Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2025-12-10","conditions":"Sarcoidosis, Pulmonary","enrollment":""},{"nctId":"NCT03029702","phase":"PHASE4","title":"Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus","status":"COMPLETED","sponsor":"Maisa N. Feghali, MD","startDate":"2018-02-28","conditions":"Gestational Diabetes, Diabetes, Gestational, Pregnancy in Diabetes","enrollment":54},{"nctId":"NCT03954041","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion","status":"TERMINATED","sponsor":"Remedy Pharmaceuticals, Inc.","startDate":"2019-10-06","conditions":"Brain Contusion","enrollment":92},{"nctId":"NCT02864953","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction","status":"TERMINATED","sponsor":"Remedy Pharmaceuticals, Inc.","startDate":"2018-08-29","conditions":"Brain Edema, Stroke, Acute","enrollment":535},{"nctId":"NCT01268683","phase":"PHASE1, PHASE2","title":"Glyburide Advantage in Malignant Edema and Stroke Pilot","status":"COMPLETED","sponsor":"Remedy Pharmaceuticals, Inc.","startDate":"2011-05-26","conditions":"Ischemic Stroke","enrollment":10},{"nctId":"NCT00965991","phase":"NA","title":"Metformin Compared to Glyburide in Gestational Diabetes","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2003-07","conditions":"Gestational Diabetes","enrollment":149},{"nctId":"NCT01794182","phase":"PHASE2","title":"Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals","status":"COMPLETED","sponsor":"Remedy Pharmaceuticals, Inc.","startDate":"2013-06-13","conditions":"Ischemic Stroke, Malignant Edema","enrollment":86},{"nctId":"NCT01454154","phase":"PHASE2","title":"Glyburide (RP-1127) for Traumatic Brain Injury (TBI)","status":"COMPLETED","sponsor":"Remedy Pharmaceuticals, Inc.","startDate":"2011-12-17","conditions":"Traumatic Brain Injury","enrollment":29},{"nctId":"NCT06589141","phase":"NA","title":"Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-01-01","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":180},{"nctId":"NCT01107717","phase":"PHASE4","title":"Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2009-01","conditions":"Diabetes","enrollment":318},{"nctId":"NCT06570980","phase":"","title":"Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.","status":"RECRUITING","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2023-08-25","conditions":"Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin","enrollment":200},{"nctId":"NCT00835991","phase":"PHASE1","title":"Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-02","conditions":"Healthy","enrollment":60},{"nctId":"NCT00836472","phase":"PHASE1","title":"Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-04","conditions":"Healthy","enrollment":60},{"nctId":"NCT05751525","phase":"","title":"Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome","status":"RECRUITING","sponsor":"Royal Devon and Exeter NHS Foundation Trust","startDate":"2016-07-01","conditions":"Neurodevelopmental Disorders, Intellectual Disability, Development Delay","enrollment":21},{"nctId":"NCT00267683","phase":"PHASE3","title":"Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2005-12","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":9},{"nctId":"NCT05688332","phase":"PHASE3","title":"Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients","status":"UNKNOWN","sponsor":"University of Zambia","startDate":"2023-08","conditions":"Diabetes Mellitus Type 2 Without Complication","enrollment":118},{"nctId":"NCT05161429","phase":"","title":"BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2021-07-01","conditions":"Diabetes Mellitus, Type 2","enrollment":550000},{"nctId":"NCT03284463","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2018-01-01","conditions":"Acute Stroke","enrollment":306},{"nctId":"NCT02919345","phase":"PHASE4","title":"Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2017-01","conditions":"Diabetes Mellitus, Type 2, Coronary Artery Disease, Carotid Artery Diseases","enrollment":98},{"nctId":"NCT01131182","phase":"PHASE4","title":"Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-06-13","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":1147},{"nctId":"NCT02460874","phase":"PHASE1, PHASE2","title":"Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2017-08-16","conditions":"Cerebral Edema, Brain Metastases","enrollment":1},{"nctId":"NCT03886922","phase":"NA","title":"The Hemodynamics Effect of Glibenclamide on Levcromakalim Assessed by High Resolution Magnetic Resonance Angiography (MRA) Technique in a Randomized Double-blind Cross-over Placebo-controlled Study With Healthy Volunteers","status":"UNKNOWN","sponsor":"Danish Headache Center","startDate":"2019-04-01","conditions":"Hemodynamics of Cranial Arteries, Headache, Cerebral Blood Flow","enrollment":15},{"nctId":"NCT02524379","phase":"PHASE1, PHASE2","title":"Spinal Cord Injury Neuroprotection With Glyburide","status":"TERMINATED","sponsor":"Ohio State University","startDate":"2017-02-14","conditions":"Acute Spinal Cord Injury","enrollment":3},{"nctId":"NCT03741530","phase":"NA","title":"Glibenclamide Advantage in Treating Edema After Intracerebral Hemorrhage","status":"COMPLETED","sponsor":"Xijing Hospital","startDate":"2018-12-15","conditions":"Intracerebral Hemorrhage","enrollment":220},{"nctId":"NCT05137678","phase":"PHASE4","title":"Evaluate the Use of Glibenclamide on Acute aSAH","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2021-10-19","conditions":"Subarachnoid Hemorrhage","enrollment":110},{"nctId":"NCT05148403","phase":"PHASE1, PHASE2","title":"To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2021-10-22","conditions":"Traumatic Brain Injury","enrollment":76},{"nctId":"NCT04859452","phase":"PHASE1","title":"A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects","status":"COMPLETED","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2021-05-26","conditions":"Healthy Subjects","enrollment":56},{"nctId":"NCT04960657","phase":"NA","title":"The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2020-10-20","conditions":"Migraine, Headache, Pain","enrollment":22},{"nctId":"NCT01132703","phase":"PHASE1","title":"Safety Study of RP-1127 (Glyburide for Injection) in Healthy Volunteers","status":"COMPLETED","sponsor":"Biogen","startDate":"2010-01-07","conditions":"Traumatic Brain Injury, Stroke","enrollment":34},{"nctId":"NCT02297126","phase":"NA","title":"A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program","status":"COMPLETED","sponsor":"Indiana University","startDate":"2015-03","conditions":"Adverse Drug Reaction","enrollment":4465},{"nctId":"NCT02726490","phase":"EARLY_PHASE1","title":"Glyburide vs Glucovance in the Treatment of GDM","status":"TERMINATED","sponsor":"Texas Tech University Health Sciences Center, El Paso","startDate":"2016-07","conditions":"Gestational Diabetes","enrollment":7},{"nctId":"NCT04231617","phase":"NA","title":"The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy Volunteers","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2020-01-20","conditions":"Hemodynamics of Cranial Arteries, Headache, Cerebral Blood Flow","enrollment":20},{"nctId":"NCT00744965","phase":"PHASE4","title":"Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2008-09-16","conditions":"Mild Gestational Diabetes","enrollment":395},{"nctId":"NCT02624830","phase":"PHASE4","title":"Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)","status":"UNKNOWN","sponsor":"Haukeland University Hospital","startDate":"2019-02-15","conditions":"Permanent Neonatal Diabetes Mellitus","enrollment":30},{"nctId":"NCT04239586","phase":"PHASE4","title":"Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes","status":"UNKNOWN","sponsor":"Haukeland University Hospital","startDate":"2017-04-18","conditions":"Maturity-Onset Diabetes of the Young, Type 3, Maturity Onset Diabetes of the Young, Type 1, Childhood Diabetes Mellitus","enrollment":30},{"nctId":"NCT03856970","phase":"PHASE1","title":"Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Ironwood Pharmaceuticals, Inc.","startDate":"2019-03-11","conditions":"Healthy Volunteers","enrollment":87},{"nctId":"NCT03855306","phase":"PHASE1","title":"A Bioequivalence Study of Glibenclamide From Glibesyn 5 mg Tablets (Medochemie LTD Cyprus) and Daonil 5 mg Tablets (Sanofi-Aventis Cyprus Ltd. )","status":"COMPLETED","sponsor":"Genuine Research Center, Egypt","startDate":"2018-06-30","conditions":"Healthy","enrollment":27},{"nctId":"NCT01697592","phase":"PHASE3","title":"Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-10-24","conditions":"Type 2 Diabetes Mellitus","enrollment":585},{"nctId":"NCT02318693","phase":"PHASE4","title":"Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-02-04","conditions":"Type 2 Diabetes Mellitus","enrollment":53},{"nctId":"NCT03569540","phase":"PHASE4","title":"Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2018-07-03","conditions":"Subarachnoid Hemorrhage, Aneurysmal","enrollment":50},{"nctId":"NCT03089333","phase":"PHASE4","title":"Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2016-07","conditions":"Hypertension, Diabetes Mellitus, Type 2, Blood Pressure","enrollment":16},{"nctId":"NCT03078725","phase":"PHASE4","title":"Failure Rate of GLyburide And Metformin Among Gestational Diabetics","status":"WITHDRAWN","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2017-06-20","conditions":"Gestational Diabetes Mellitus, Class A2","enrollment":""},{"nctId":"NCT01215331","phase":"PHASE3","title":"Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2010-08","conditions":"Gestational Diabetes Mellitus","enrollment":73},{"nctId":"NCT00194896","phase":"NA","title":"Preferred Treatment of Type 1.5 Diabetes","status":"COMPLETED","sponsor":"University of Washington","startDate":"2000-02","conditions":"Type 2 Diabetes Mellitus","enrollment":64},{"nctId":"NCT02627898","phase":"PHASE2","title":"Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Centro Universitario de Ciencias de la Salud, Mexico","startDate":"2016-01","conditions":"Type 2 Diabetes Mellitus","enrollment":24},{"nctId":"NCT00451620","phase":"PHASE2","title":"Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2003-11","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT00232583","phase":"NA","title":"Preservation of Beta-cell Function in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2003-11","conditions":"Type 2 Diabetes Mellitus","enrollment":58},{"nctId":"NCT00279045","phase":"PHASE3","title":"Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2000-01-03","conditions":"Diabetes Mellitus, Type 2","enrollment":4426},{"nctId":"NCT00333723","phase":"PHASE4","title":"AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2000-07-28","conditions":"Diabetes Mellitus, Type 2","enrollment":245},{"nctId":"NCT02624817","phase":"PHASE4","title":"Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2015-12","conditions":"Permanent Neonatal Diabetes Mellitus","enrollment":90},{"nctId":"NCT01822548","phase":"PHASE3","title":"Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes","status":"COMPLETED","sponsor":"Azienda Ospedaliero-Universitaria di Parma","startDate":"2010-10","conditions":"Type 2 Diabetes","enrollment":64},{"nctId":"NCT01340768","phase":"PHASE3","title":"Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-06-22","conditions":"Type 2 Diabetes Mellitus","enrollment":870},{"nctId":"NCT01357135","phase":"","title":"An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-07-15","conditions":"Type 2 Diabetes Mellitus","enrollment":3453},{"nctId":"NCT02830048","phase":"PHASE2","title":"Low dosE GlibENclamide in Diabetes Part A","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2016-07","conditions":"Diabetes Mellitus, Type 2","enrollment":16},{"nctId":"NCT01798706","phase":"PHASE3","title":"Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":350},{"nctId":"NCT00379769","phase":"PHASE3","title":"RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2001-04","conditions":"Diabetes Mellitus, Type 2","enrollment":4447},{"nctId":"NCT00393718","phase":"PHASE3","title":"Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":400},{"nctId":"NCT01698931","phase":"PHASE4","title":"Efficacy of Repaglinide in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-04-26","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":9},{"nctId":"NCT01605773","phase":"PHASE4","title":"Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2001-11-08","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":51},{"nctId":"NCT01934816","phase":"NA","title":"Incretin and KATP Channels","status":"TERMINATED","sponsor":"Katarina Kos","startDate":"2013-06","conditions":"Healthy Subjects","enrollment":2},{"nctId":"NCT02080377","phase":"PHASE3","title":"A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2014-07","conditions":"Pregnancy, Gestational Diabetes","enrollment":23},{"nctId":"NCT02476760","phase":"","title":"Incretin-based Drugs and Acute Pancreatitis","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Diabetes Mellitus, Type 2","enrollment":1417914},{"nctId":"NCT00388986","phase":"PHASE1","title":"A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2006-10","conditions":"Diabetes Mellitus Type 2","enrollment":18},{"nctId":"NCT01563120","phase":"PHASE4","title":"A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2012-01","conditions":"Gestational Diabetes Mellitus","enrollment":108},{"nctId":"NCT00734669","phase":"","title":"Risk of Hypoglycemia in Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Giessen","startDate":"2008-07","conditions":"Type 2 Diabetes","enrollment":12},{"nctId":"NCT01944618","phase":"","title":"forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2013-10","conditions":"Type 2 Diabetes","enrollment":5000},{"nctId":"NCT02201602","phase":"PHASE4","title":"Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study","status":"COMPLETED","sponsor":"Khoo Teck Puat Hospital","startDate":"2014-08","conditions":"Diabetes","enrollment":8},{"nctId":"NCT02145611","phase":"PHASE4","title":"Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension","status":"COMPLETED","sponsor":"Dr. José Fernando Vilela-Martin MD PhD","startDate":"2013-07","conditions":"Type 2 Diabetes Mellitus, Hypertension, Endothelial Dysfunction","enrollment":50},{"nctId":"NCT02815787","phase":"PHASE1","title":"The Drug -Drug Interaction of SP2086 and Glyburide","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2014-03","conditions":"Type 2 Diabetes","enrollment":16},{"nctId":"NCT01947699","phase":"PHASE4","title":"Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide","status":"WITHDRAWN","sponsor":"University of Pittsburgh","startDate":"2013-09","conditions":"Gestational Diabetes","enrollment":""},{"nctId":"NCT02456428","phase":"","title":"Incretin-based Drugs and the Risk of Heart Failure","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Type 2 Diabetes Mellitus","enrollment":1499650},{"nctId":"NCT02128022","phase":"PHASE1","title":"Cardioprotective Effects of GLP-1 and Their Mechanisms","status":"COMPLETED","sponsor":"Papworth Hospital NHS Foundation Trust","startDate":"2014-07","conditions":"Angina Pectoris","enrollment":32},{"nctId":"NCT02475499","phase":"","title":"Incretin-based Drugs and Pancreatic Cancer","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Diabetes Mellitus, Type 2","enrollment":886172},{"nctId":"NCT01540396","phase":"NA","title":"Gestational Diabetes Diagnostic Methods","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2012-02","conditions":"Gestational Diabetes","enrollment":47},{"nctId":"NCT00486187","phase":"NA","title":"Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study","status":"COMPLETED","sponsor":"Dr. Milan Gupta","startDate":"2006-04","conditions":"Type 2 Diabetes Mellitus","enrollment":103},{"nctId":"NCT02607410","phase":"PHASE4","title":"Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2010-01","conditions":"Type 2 Diabetes Mellitus","enrollment":40},{"nctId":"NCT00700856","phase":"PHASE4","title":"Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial","status":"UNKNOWN","sponsor":"Italian Society of Diabetology","startDate":"2008-09","conditions":"Type 2 Diabetes Mellitus, Cardiovascular Disease","enrollment":3371},{"nctId":"NCT00313313","phase":"PHASE3","title":"A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2006-04","conditions":"Diabetes","enrollment":768},{"nctId":"NCT02406950","phase":"PHASE3","title":"Sitagliptin and Endothelial Dysfunction","status":"UNKNOWN","sponsor":"Kyunghee University Medical Center","startDate":"2015-02","conditions":"Healthy","enrollment":10},{"nctId":"NCT01998113","phase":"","title":"Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2013-03","conditions":"Gestational Diabetes Mellitus","enrollment":2509},{"nctId":"NCT01329016","phase":"PHASE1, PHASE2","title":"Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)","status":"UNKNOWN","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2011-07","conditions":"Gestational Diabetes Mellitus","enrollment":360},{"nctId":"NCT00935363","phase":"PHASE1","title":"Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2010-02","conditions":"Healthy","enrollment":""},{"nctId":"NCT00608179","phase":"NA","title":"Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2002-08","conditions":"Type 2 Diabetes","enrollment":32},{"nctId":"NCT01584232","phase":"PHASE3","title":"A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-04","conditions":"Type 2 Diabetes Mellitus","enrollment":361},{"nctId":"NCT02255006","phase":"NA","title":"Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury","status":"UNKNOWN","sponsor":"Kyunghee University Medical Center","startDate":"2014-05","conditions":"Healthy","enrollment":36},{"nctId":"NCT01716338","phase":"PHASE1","title":"Glyburide Healthy Volunteer Study","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-01","conditions":"Healthy Volunteers","enrollment":21},{"nctId":"NCT02183428","phase":"PHASE1","title":"Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2008-05","conditions":"Healthy","enrollment":20},{"nctId":"NCT01940302","phase":"EARLY_PHASE1","title":"Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Shaoguan University","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":71},{"nctId":"NCT01867502","phase":"PHASE4","title":"Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2014-04","conditions":"Diabetes Mellitus, Type 2, Hypoglycemic Agents, Diabetic Blood Glucose Monitoring","enrollment":20},{"nctId":"NCT02091336","phase":"PHASE4","title":"Oral Antidiabetic Agents in Pregnancy","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2014-01","conditions":"Gestational Diabetes","enrollment":80}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":2,"reaction":"BLOOD SODIUM INCREASED"},{"count":2,"reaction":"METABOLIC ACIDOSIS"},{"count":2,"reaction":"RENAL FAILURE ACUTE"},{"count":2,"reaction":"TREMOR"},{"count":1,"reaction":"ABASIA"},{"count":1,"reaction":"ACINETOBACTER INFECTION"},{"count":1,"reaction":"AMNESIA"},{"count":1,"reaction":"ASPARTATE AMINOTRANSFERASE"},{"count":1,"reaction":"ATELECTASIS"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":489,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"glybenclamide","genericName":"glybenclamide","companyName":"HaEmek Medical Center, Israel","companyId":"haemek-medical-center-israel","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}